Prognosis of heart transplant candidates stabilized on medical therapy;Pronóstico de una población inicialmente candidata a trasplante cardíaco controlada con tratamiento médico

Revista Espanola de Cardiologia

Volumn 58, Issue 10, 2005, Pages 1162-1170

  Fernández Yáñez, Juan ^a,c   Palomo, Jesús ^a   Torrecilla, Esteban G ^a   Pascual, David ^a   Garrido, Gregorio ^b   Gómez de Diego, José J ^a   Domínguez, Marta ^a   Almendral, Jesús ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b ORGANIZACIÓN NACIONAL DE TRASPLANTES   (Spain)

^c NONE   (Spain)

Author keywords

Beta blockers; Heart failure; Prognosis; Transplantation

Indexed keywords

AMIODARONE; AMLODIPINE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIURETIC AGENT; HYDRALAZINE; NITRIC ACID DERIVATIVE; SPIRONOLACTONE;

ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART TRANSPLANTATION; HUMAN; KAPLAN MEIER METHOD; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 28444487482     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13079910     Document Type: Article

References (33)

1. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986;314:1547-22.
2. The CONSENSUS trial study group: effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:428-35.
3. The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
4. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al, for The US Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349-55.
5. Packer M, Cotas AJS, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of Carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651-8.
6. CIBIS-II Investigators and Committees. The cardiac insufficiency Bisoprolol study II (CIBIS II): a randomised trial. Lancet. 1999; 353:9-13.
7. MERIT-HF Study group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet. 1999;353:2001-7.
8. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Pérez A, et al. The effect of spirolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341:709-17.
9. Packer M, O'Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, et al, for The Prospective Randomized Amlodipine Survival Evaluation Study Group. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med. 1996;335:1107-4.
10. Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJV, Michelson EL, et al, and CHARM Investigators and Committees. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003;362:759-66.
11. Packer M. Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation. 1985;72:681-5.
12. Anguita M, Arizón JM, Bueno G, Latre JM, Sancho M, Torres F, et al. Clinical and hemodynamic predictors of survival in patients aged < 65 years with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol. 1993;72:413-7.
13. Kjekshus J. Arrhythmias and mortality in congestive heart failure. Am J Cardiol. 1990;65:421-81.
14. Zipes DP, Wellens HJJ. Sudden cardiac death. Circulation. 1998; 98:2334-51.
15. Bayés de Luna A, Coumel P, Leclercq JF. Ambulatory sudden death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J. 1989;117:151-9.
16. Sweeney MO, Ruskin JN, Garan H, McGovern BA, Guy ML, Torchiana DF, et al. Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation. 1995;92:3273-81.
17. Böcker D, Bänsch D, Heinecke A, Weber M, Brunn J, Hammel D, et al. Potential benefit from implantable cardioverter-defibrillator therapy in patients with and without heart failure. Circulation. 1998;98:1636-43.
18. Josephson ME, Callans DJ, Buxton AE. The role of the implantable cardioverter-defibrillator for prevention of sudden cardiac death. Ann Intern Med. 2000;133:901-10.
19. Sandner SE, Wieselthaler G, Zuckermann A, Taghavi S, Schmidinger H, Pacer R, et al. Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation. Circulation. 2001;104 Suppl I:171-6.
20. Moss AJ, Zareba W, Hall J, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-83.
21. Pulpón LA, Almenar L, Crespo MG, Silva L, Segovia J, Manito N, et al. Guías de actuación clínica de la Sociedad Española de Cardiología. Trasplante cardíaco y de corazón-pulmones. Rev Esp Cardiol. 1999; 52:821-39.
22. Mudge GH, Goldstein S, Addonizio LJ, Caplan A, Mancini D, Levine TB, et al. Task force 3: recipient guidelines/prioritization. 24th Bethesda conference: cardiac transplantation. J Am Coll Cardiol. 1993;22:21-31.
23. Costanzo MR, Augustine S, Bourge R, Bristow M, O'Connell JB, Driscoll D, et al. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation Council on Clinical Cardiology, American Heart Association. Circulation. 1995;92:3593-612.
24. Rickenbacher PR, Trindade PT, Haywood GA, Vangelos RH, Schroeder JS, Willson K, et al. Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival. J Am Coll Cardiol. 1996;27:1192-7.
25. Nägele H, Rödiger W. Sudden death and tailored medical therapy in electives candidates for heart transplantation. J Heart Lung Transplant. 1999;18:869-76.
26. Anguita M, Arizón JM, Torres F, Giménez D, Gallardo A, Ciudad R, et al. Incidencia, mecanismos y factores clínicos predictores de muerte súbita en pacientes con insuficiencia cardíaca severa evaluados con vistas a trasplante cardíaco. Rev Esp Cardiol. 1994;47:658-65.
27. Butler J, Khadim G, Paul KM, Davis SF, Kronenberg MW, Chomsky DB, et al. Selection of patients for heart transplantation in the current era of heart failure therapy. J Am Coll Cardiol. 2004;43:787-93.
28. Packer M, Lee WH, Kessler PD, Gottlieb SS, Bernstein JL, Kukin ML. Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure. Circulation. 1987;75 Suppl IV:80-92.
29. Crespo Leiro MG, Paniagua Martín MJ. Tratamiento de la insuficiencia cardíaca refractaria o avanzada. Rev Esp Cardiol. 2004: 57:869-83.
30. Hall SA, Cigarroa CG, Marcoux L, Risser RC, Grayburn PA, Eichhorn EJ. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta adrenergic blockade. J Am Coll Cardiol. 1995;25:1154-61.
31. Kadish Alan, Dyer A, Daubert JP, Quigg R, Estes M, Anderson KP, et al, for the Defibrillators in non-ischemic cardiomyopathy treatment evaluation (DEFINITE) investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-8.
32. The antiarrhythmics versus implantable defibrillators (AVID) investigators. A comparison of antyarrhytmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-83.
33. Saba S, Atiga WL, Barrington W, Ganz LI, Kormos RL, MacGowan GA, et al. Select patients listed for cardiac transplantation may benefit from defibrillator implantation regardless of an established indication. J Heart Lung Transplant. 2003;22:411-8.